<div id="readability-page-1">SSY Group ( (HK:2005) ) has shared an announcement.SSY Group has executed a share purchase on the open market under its Restricted Share Award Scheme, with the scheme trustee acquiring 1,000,000 shares on 24 June 2026 using the company’s internal resources. The newly purchased shares, representing about 0.034% of issued share capital, lift the trustee’s holdings to roughly 0.362%, reinforcing the group’s long-term incentive framework for selected participants and signaling continued commitment to employee and management alignment.The board retains full discretion over future awards under the scheme and will periodically review the number of shares to be granted to eligible participants. This measured use of buybacks for share awards may support capital management objectives, while potentially enhancing talent retention and aligning stakeholders’ interests with the company’s performance over time. The most recent analyst rating on (HK:2005) stock is a Buy with a HK$5.00 price target. To see the full list of analyst forecasts on SSY Group stock, see the HK:2005 Stock Forecast page. <div> More about SSY Group SSY Group Limited is a Hong Kong-listed company incorporated in the Cayman Islands and traded under stock code 2005. The group operates in the pharmaceutical and healthcare sector, focusing on the development and production of medical products for both domestic and international markets. Average Trading Volume: 6,490,396 Technical Sentiment Signal: Sell Current Market Cap: HK$5.96B </div></div>

02005

SSY Group (HK:2005) purchased 1,000,000 shares on the open market under its Restricted Share Award Scheme using internal resources. This acquisition increases the trustee's holdings to approximately 0.362% of issued share capital, reinforcing long-term incentives for employees and management. The board retains discretion over future awards. Analysts maintain a 'Buy' rating with a HK$5.00 price target.

SSY Group Boosts Share Award Pool with Open-Market Purchase